Why AD Still Needs Better Solutions: Role of IL-13 and Lebrikizumab

    Dates:
    Organizer:
    Virtual Medical Academy
    Location:
    Online
    Specialty:
    Dermatology
    Format:
    Online

    This webinar explores the role of IL-13 in atopic dermatitis and itch, discussing what makes lebrikizumab different in terms of long-term depth and stability of response, particularly in challenging areas like hands and face, with real patient experience data.

    Full details and registration

    This event has ended

    Concluded 6 months ago · Apr 24, 2026

    Browse upcoming
    Why AD Still Needs Better Solutions: Role of IL-13 and Lebrikizumab1 / 1

    1 photos · tap to enlarge

    Apr 24 – Apr 24, 2026See all April 2026 events

    Why AD Still Needs Better Solutions: Role of IL-13 and Lebrikizumab

    Listed 7 Apr 2026

    About this event

    This webinar explores the role of IL-13 in atopic dermatitis and itch, discussing what makes lebrikizumab different in terms of long-term depth and stability of response, particularly in challenging areas like hands and face, with real patient experience data.

    Ratings & Reviews

    No ratings yet
    FREE WEEKLY DIGEST

    Never miss a CME event

    Get curated events for your specialty — every week